has been cited by the following article(s):
[1]
|
Topical application of sh-oligopeptide-1 and clinical trials with cosmetic preparations: risk or fraud?
Cutaneous and Ocular Toxicology,
2023
DOI:10.1080/15569527.2023.2234020
|
|
|
[2]
|
Topical application of sh-oligopeptide-1 and clinical trials with cosmetic preparations: risk or fraud?
Cutaneous and Ocular Toxicology,
2023
DOI:10.1080/15569527.2023.2234020
|
|
|